HealthEquity, Inc (HQY) PT Raised to $77 at Chardan Capital Markets

Go back to HealthEquity, Inc (HQY) PT Raised to $77 at Chardan Capital Markets

HealthEquity, Inc (HQY) PT Raised to $61 at Baird

March 20, 2018 8:20 AM EDT

Baird raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $61.00 (from $49.00) while maintaining a Neutral rating.

... More

HealthEquity, Inc (HQY) PT Raised to $70 at SunTrust Robinson Humphrey

March 20, 2018 5:06 AM EDT

SunTrust Robinson Humphrey raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $70.00 (from $60.00) while maintaining a Buy rating.

... More

HealthEquity, Inc (HQY) PT Raised to $66 at KeyBanc

March 20, 2018 4:21 AM EDT

KeyBanc raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $66.00 (from $62.00) while maintaining a Overweight rating.

... More

HealthEquity, Inc (HQY) PT Raised to $68 at Oppenheimer

March 20, 2018 2:24 AM EDT

Oppenheimer raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $68.00 (from $58.00) while maintaining a Outperform rating.

... More

HealthEquity, Inc (HQY) PT Raised to $65 at Cantor Fitzgerald Following 4Q

March 20, 2018 2:20 AM EDT

Cantor Fitzgerald raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $65.00 (from $60.00) while maintaining a Overweight rating following the company's 4Q earnings report. HQY revenue of $60.4 million, above FactSet consensus and estimates of $58 million. Adjusted EBITDA grew 44.5% as the company continues to scale.... More